AG-1024 is primarily utilized in biochemical and pharmacological research as a potent and selective inhibitor of the insulin-like growth factor 1 receptor (IGF-1R). It is commonly employed in studies focused on understanding the role of IGF-1R in cellular signaling pathways, particularly in cancer research. By inhibiting IGF-1R, AG-1024 helps researchers investigate the receptor's involvement in tumor growth, proliferation, and survival. This compound is also used to explore potential therapeutic strategies targeting IGF-1R in various cancers, such as breast, prostate, and lung cancer. Additionally, AG-1024 is applied in studies examining metabolic processes and the interplay between insulin and IGF-1 signaling pathways. Its ability to selectively block IGF-1R makes it a valuable tool for dissecting the molecular mechanisms underlying diseases associated with this receptor.